Eyenovia Inc (EYEN)
0.1197
-0.04
(-23.76%)
USD |
NASDAQ |
Jan 08, 16:00
0.1136
-0.01
(-5.10%)
Pre-Market: 08:35
Eyenovia SG&A Expense (Quarterly): 3.729M for Sept. 30, 2024
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| TFF Pharmaceuticals Inc | 1.955M |
| Johnson & Johnson | 5.278B |
| Merck & Co Inc | 2.731B |
| Aptevo Therapeutics Inc | 2.11M |
| Amneal Pharmaceuticals Inc | 118.69M |